William Blair Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
46,375
-5,234
-10% -$284K 0.01% 343
2026
Q1
$3.24M Buy
51,609
+70
+0.1% +$5.6K 0.01% 344
2025
Q4
$4.91M Buy
+51,539
New +$5.05M 0.01% 336
2018
Q1
– Sell
-1,017,823
Closed -$25.2M – 437
2017
Q4
$25.2M Sell
1,017,823
-495,740
-33% -$13.7M 0.1% 215
2017
Q3
$44.2M Sell
1,513,563
-19,892
-1% -$549K 0.16% 155
2017
Q2
$42.5M Sell
1,533,455
-16,570
-1% -$440K 0.15% 158
2017
Q1
$38.5M Sell
1,550,025
-37,986
-2% -$924K 0.15% 160
2016
Q4
$34.3M Sell
1,588,011
-22,772
-1% -$497K 0.14% 170
2016
Q3
$38.3M Buy
+1,610,783
New +$38.4M 0.15% 168

Other funds holding BSX

William Blair Investment Management's BSX Position: Q2 2026 in Review

William Blair Investment Management reduced its Boston Scientific (BSX) stake by 10% in Q2 2026, selling an estimated $284K and leaving 46,375 shares worth $1.98M. The position accounts for 0.01% of the portfolio, ranked #343.

William Blair Investment Management first reported a position in BSX in Q3 2016 and has held it in 9 quarters since. The position peaked at $44.2M in Q3 2017. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • William Blair Investment Management held 46,375 shares of Boston Scientific worth $1.98M as of Q2 2026.
  • William Blair Investment Management sold 5,234 Boston Scientific shares in Q2 2026, an estimated $284K.
  • Boston Scientific made up 0.01% of William Blair Investment Management's portfolio in Q2 2026, its #343 holding.
  • William Blair Investment Management first reported a position in Boston Scientific in Q3 2016 and has held it in 9 quarters since.
  • William Blair Investment Management's Boston Scientific position peaked at $44.2M in Q3 2017.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.